Leon Kircik
University of Louisville(US)Indianapolis Zoo(US)University Medical Center(US)DermResearch (United States)(US)Skin Research Center(FR)University School(US)Gold Skin Care Center(US)Indiana University School of MedicineIndiana University – Purdue University Indianapolis(US)Indiana University(US)Icahn School of Medicine at Mount Sinai(US)
Publications by Year
Research Areas
Dermatology and Skin Diseases, Acne and Rosacea Treatments and Effects, Psoriasis: Treatment and Pathogenesis, Skin Protection and Aging, Nail Diseases and Treatments
Most-Cited Works
- → Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis(2015)792 cited
- → Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)(2015)659 cited
- → Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*(2020)563 cited
- → Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies(2021)281 cited
- → Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial(2022)261 cited